These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10955356)

  • 1. Elevated homocysteine levels in patients with Raynaud's syndrome.
    Danese S; Candelli M; Gasbarrini A
    J Rheumatol; 2000 Aug; 27(8):2051. PubMed ID: 10955356
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
    Marasini B; Casari S; Bestetti A; Maioli C; Cugno M; Zeni S; Turri O; Guagnellini E; Biondi ML
    J Rheumatol; 2000 Nov; 27(11):2621-3. PubMed ID: 11093443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly.
    Lewerin C; Ljungman S; Nilsson-Ehle H
    J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and vascular diseases.
    Marasini B; Massarotti M; Biondi ML
    Circulation; 2002 Aug; 106(7):e33. PubMed ID: 12176969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemorrheology and neurovascular syndromes of the extremities].
    Sergio G; Artale F; Francisci A; Giunti P; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():481-5. PubMed ID: 6673031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon.
    Letizia C; Danese C; D'Erasmo E
    J Rheumatol; 1999 Mar; 26(3):759-60. PubMed ID: 10090204
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incomplete Raynaud's syndrome with extensive osteolysis, acrosclerosis, multiple visceral lesions. Systemic scleroderma].
    Michel PJ; Frieh P; Cretin J; Cassin B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):526-31. PubMed ID: 5585213
    [No Abstract]   [Full Text] [Related]  

  • 11. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
    Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and cold provocation in health, primary Raynaud's phenomenon, and progressive systemic sclerosis.
    Dörffler-Melly J; Lüscher TF; Wenk M; Wen S; Bollinger A; Franzeck UK
    Microvasc Res; 1996 Sep; 52(2):193-7. PubMed ID: 8901448
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rheology of giant capillary occlusion in secondary Raynaud's phenomenon within the scope of systemic sclerosis].
    Schmid-Schönbein H; Goebel W; Perkkiö J; Polster H; Jacobs M; Lemmens HA
    Vasa Suppl; 1989; 27():61-3. PubMed ID: 2623545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Scleroderma, pulmonary hypertension and Raynaud's syndrome].
    Duclós F; Bohórquez A; Zambrano A; Armenta J
    Rev Esp Cardiol; 1968 Apr; 21(2):223-33. PubMed ID: 5739705
    [No Abstract]   [Full Text] [Related]  

  • 15. [Raynaud's phenomenon in the tongue of a patient with sclerodermia].
    Klemp P; Staberg B; Thomsen K
    Ugeskr Laeger; 1983 Jan; 145(5):333. PubMed ID: 6845496
    [No Abstract]   [Full Text] [Related]  

  • 16. Scleroderma associated with Raynaud's disease.
    Lantz H
    J Oral Med; 1967 Jul; 22(3):103-7. PubMed ID: 5235027
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.
    Keenan EJ; Porter JM
    Surgery; 1983 Aug; 94(2):204-9. PubMed ID: 6308842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Raynaud's phenomenon and scleroderma (author's transl)].
    Merlen JF
    Ann Cardiol Angeiol (Paris); 1980 Jun; 29(4):333-7. PubMed ID: 7447353
    [No Abstract]   [Full Text] [Related]  

  • 19. Scleroderma, the heart and myocardial Raynaud's phenomenon.
    Nath AR; Mehta PJ
    J Assoc Physicians India; 1993 Oct; 41(10):631-2. PubMed ID: 8294319
    [No Abstract]   [Full Text] [Related]  

  • 20. Raynaud's phenomenon and scleroderma; a case report and psychodynamic formulation.
    RICHARDSON HB
    Psychoanal Rev; 1955 Jan; 42(1):24-38. PubMed ID: 14371880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.